This inventor holds 3 USPTO granted patents and 4 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignees: National Center of Neurology and Psychiatry, Nippon Shinyaku Company, Ltd.. Active years: 2018-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
3 out of 43 
3 out of 229 Years Active: 2018-2024
Title: Yuichiro Tone: Innovator in Antisense Nucleic Acids
Introduction
Yuichiro Tone is a notable inventor based in Ibaraki, Japan. He has made significant contributions to the field of biotechnology, particularly in the development of antisense nucleic acids. With a total of three patents to his name, Tone's work has the potential to impact genetic therapies.
Latest Patents
Among his latest patents, Tone has developed an oligomer that facilitates exon 45 skipping in the human dystrophin gene. This innovation is crucial for advancing treatments for muscular dystrophies, showcasing his commitment to addressing critical health challenges.
Career Highlights
Throughout his career, Yuichiro Tone has worked with reputable organizations, including Nippon Shinyaku Company, Ltd. and the National Center of Neurology and Psychiatry. His experience in these institutions has allowed him to collaborate with leading experts in the field.
Collaborations
Some of his notable coworkers include Yukiko Enya and Shin'ichi Takeda. Their collective expertise has contributed to the success of Tone's research and innovations.
Conclusion
Yuichiro Tone's contributions to the field of antisense nucleic acids highlight his role as a significant inventor in biotechnology. His work continues to pave the way for advancements in genetic therapies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile